Triple combination of montelukast or tiotropium and inhaled corticosteroids plus long-acting β2-agonist in persistent asthma

被引：0
|
作者：
Hoshino, Makoto [1 ]
Akitsu, Kenta [2 ]
Ohtawa, Junichi [2 ]
机构：
[1] Int Univ Hlth & Welf, Atami Hosp, Dept Internal Med, Div Clin Allergy, Atami, Japan
[2] Int Univ Hlth & Welf, Atami Hosp, Dept Radiol, Atami, Japan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.PA5006
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA5006
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Indacaterol: A Novel Long-Acting β2-Agonist
    Ray, Shaunta' M.
    McMillen, James C.
    Treadway, Sarah A.
    Helmer, Robert S.
    Franks, Andrea S.
    PHARMACOTHERAPY, 2012, 32 (05): : 456 - 474
  • [42] Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma The BELT Randomized Clinical Trial
    Wechsler, Michael E.
    Yawn, Barbara P.
    Fuhlbrigge, Anne L.
    Pace, Wilson D.
    Pencina, Michael J.
    Doros, Gheorghe
    Kazani, Shamsah
    Raby, Benjamin A.
    Lanzillotti, Jane
    Madison, Suzanne
    Israel, Elliot
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (16): : 1720 - 1730
  • [43] CAPTAIN: Effects of asthma onset in childhood versus adulthood on response to triple therapy in patients with inadequately controlled asthma on inhaled corticosteroid/long-acting β2-agonist
    Busse, W.
    Abbott, C. B.
    Chang, S.
    Crawford, J.
    Maselli, D. J.
    Nathan, R.
    Stanaland, M. D.
    Kerwin, E.
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 561 - 561
  • [44] Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma
    Chantaphakul, Hiroshi
    Ruxrungtham, Kiat
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (05) : 631 - 642
  • [45] Comparison Of Inhaled Corticosteroid Monotherapy And Long Acting 2-Agonist/Inhaled Corticosteroid Combination Therapy In Patients With Cough Variant Asthma
    Miyazawa, N.
    Sato, T.
    Hayashi, M.
    Yamamoto, M.
    Tomaru, K.
    Tsukahara, T.
    Takahashi, R.
    Sasaki, M.
    Kaneko, T.
    Ishigatsubo, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [46] CAPTAIN: Effects of Asthma Onset in Childhood versus Adulthood on Response to Triple Therapy in Patients with Inadequately Controlled Asthma on Inhaled Corticosteroid/Long-Acting β2-Agonist
    Busse, W. W.
    Abbott, C. B.
    Chang, S.
    Crawford, J.
    Maselli, D.
    Nathan, R.
    Stanaland, M. D.
    Kerwin, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [47] Lung Blood Flow Must Be Considered When Prescribing a Long-Acting β2-Agonist/Inhaled Corticosteroid Combination
    Cazzola, Mario
    Matera, Maria Gabriella
    CHEST, 2012, 141 (05) : 1134 - 1136
  • [48] The long-acting β2-agonist salmeterol xinafoate:: effects on airway inflammation in asthma
    Roberts, JA
    Bradding, P
    Britten, KM
    Walls, AF
    Wilson, S
    Gratziou, C
    Holgate, ST
    Howarth, PH
    EUROPEAN RESPIRATORY JOURNAL, 1999, 14 (02) : 275 - 282
  • [49] Combination inhaled steroid and long-acting beta2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
    Ximena Rojas-Reyes, Maria
    Garcia Morales, Olga M.
    Dennis, Rodolfo J.
    Karner, Charlotta
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (06): : CD008532
  • [50] Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medications
    Hauber, A. Brett
    Mohamed, Ateesha F.
    Johnson, F. Reed
    Meddis, David
    Wagner, Samuel
    O'Dowd, Liza
    ALLERGY AND ASTHMA PROCEEDINGS, 2009, 30 (02) : 139 - 147
12345